Retmarker certified technology enables highly efficient screening of Diabetic Retinopathy. Human burden on Diabetic Retinopathy Screening Programs may be reduced by up to 75%.

Learn more

  • Screening becomes more cost-effective
  • More population can be screened using the same resources

Diabetic Retinopathy (DR) is the sight-threatening complication of diabetes and the main cause of vision loss in the working age population. It progresses without symptoms until irreversible vision loss occurs. According to the International Diabetes foundation, 382 million people have diabetes in 2013.

Step1 - Field Station
Step2 - Computer
Step3 - Retmarker
Step4 - Technician
Step5 - Report

Retmarker covered in specialised publications in the field of Vision Health

Professor Emeritus José Cunha-Vaz receives the Euretina Award 2016

Major UK study confirms effectiveness of ground-breaking RETMARKER Diabetic Retinopathy screening technology

New Screening Program with Retmarker technology deployed

Our clinical partner receives the Pfizer Award 2015 for Clinical Research

Added Value of Automated Grading in DR Screening presented at EASDec 2015

We have a new distributor in Brazil

EMA issues Letter of Support for Micro-Aneurysm Formation Rate biomarker

Added Value of Automated Grading in Screening is confirmed in recent article

Professor Cunha-Vaz distinguished for his contributions to Ophthalmology

Critical Health is now Retmarker

Published study suggests Retmarker can be a Biomarker for response to CSME treatment

ARVO's Weisenfeld Award 2014 distinguishes Professor Cunha-Vaz

Critical Health establishes partnership with Universidade de Coimbra

Successful participation in HCIST 2013

Article in RETINA corroborates that Retmarker enables a suitable predictive marker for CSME

Prof. Cunha-Vaz receives the 2012 BIAL Award of Clinical Medicine

RetmarkerDR used in a proposed Surrogate Outcome for Diabetic Retinopathy Progression

Microaneurysm Turnover article published at Current Biomarker Findings

Publication in 'Diabetes Care' recognizes that Retmarker "predicts risk of development of CSME"

Critical Health presented Retmarker at the VIII CAO

RetmarkerDR recommended for initial stages of Diabetic Retinopathy

Critical Health Invited to Open Session at EURETINA'12

Automatic quality assessment for fundus photographs

A Critical Health participa na campanha da APDP: "Juntos vamos dar a cara pela Diabetes"

Retmarker technology underlies recognition as Microsoft Startup of the Day

Critical Health Innovation in Retinal Disease Management at EURETINA'11

Critical Health showcases Retmarker and Medisoft in XVIII Pan-American Course of the PAAO

Critical Health incorporates Medisoft's Electronic Medical Record solution

Retmarker receives Cotec-Unicer honourable mention for innovative products

Critical Health and Retmarker certification

Critical Health wins at the "European IT Excellence Awards"